Back
MoonLake Immunotherapeutics Stock Price Chart
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Buy
54
MLTX
MoonLake Immunotherapeutics
Last Price:
44.95
Seasonality Move:
62.44%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- The current trend is relatively stagnant and MLTX is experiencing selling pressure, which indicates risk of future bearish movement.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.3 | Buy |
| 20-day SMA: | 43.51 | Sell |
| 50-day SMA: | 46.86 | Sell |
| 200-day SMA: | 52.61 | Sell |
| 8-day EMA: | 42.35 | Buy |
| 20-day EMA: | 43.62 | Sell |
| 50-day EMA: | 46.82 | Sell |
| 200-day EMA: | 47.24 | Sell |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.66 | Sell |
| Relative Strength Index (14 RSI): | 41.4 | Sell |
| Chaikin Money Flow: | -322194 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.9 - 46.78) | Sell |
| Bollinger Bands (100): | (45.99 - 59.01) | Sell |
MoonLake Immunotherapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 42.43 while MLTX 8-day simple moving average is 42.30, which is a Buy signal.
- The stock price of MLTX is 42.43 while MoonLake Immunotherapeutics 20-day SMA is 43.51, which makes it a Sell.
- MoonLake Immunotherapeutics 50-day simple moving average is 46.86 while MLTX share price is 42.43, making it a Sell technically.
- MLTX stock price is 42.43 and MoonLake Immunotherapeutics 200-day simple moving average is 52.61, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Buy
54
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a Buy
The current MoonLake Immunotherapeutics [MLTX] share price is $42.43. The Score for MLTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
2.67B
Price in USD:
42.43
Share Volume:
337.78K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
64.98
52-Week Low:
22.12
Buy
54
MoonLake Immunotherapeutics (MLTX)
is a Buy
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?
The MoonLake Immunotherapeutics stock price is 42.43 USD today. -
Will MLTX stock go up or go down?
MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is MoonLake Immunotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is not overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 42.43 while MLTX 8-day exponential moving average is 42.35, which is a Buy signal.
- The stock price of MLTX is 42.43 while MoonLake Immunotherapeutics 20-day EMA is 43.62, which makes it a Sell.
- MoonLake Immunotherapeutics 50-day exponential moving average is 46.82 while MLTX share price is 42.43, making it a Sell technically.
- MLTX stock price is 42.43 and MoonLake Immunotherapeutics 200-day simple moving average is 47.24, creating a Sell signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.37 per share, a decrease this year of $0.29 per share, and a decrease next year of $0.59 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
- MLTX Moving Average Covergence Divergence (MACD) indicator is -1.66, suggesting MoonLake Immunotherapeutics is a Sell
- MoonLake Immunotherapeutics Relative Strength Index (RSI) is 41.4, which suggest MoonLake Immunotherapeutics is oversold
- The Bollinger Bands (25) for MoonLake Immunotherapeutics is (41.9 - 46.78), which suggest MoonLake Immunotherapeutics is a Sell
- The Bollinger Bands (100) for MoonLake Immunotherapeutics is (45.99 - 59.01), which suggest MoonLake Immunotherapeutics is a Sell
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.